LAZZARI, Grazia et al. The Impact of KEYNOTE-522 Related Immune-Related Adverse Events on Concurrent Adjuvant Whole Breast Radiotherapy in the Real World: A Case Series: KEYNOTE-522 and adjuvant hypofractionated RT. Archives of Breast Cancer, [S. l.], v. 12, n. 2, p. 231–235, 2025. DOI: 10.32768/abc.2025122231-235. Disponível em: https://archbreastcancer.com/index.php/abc/article/view/1088. Acesso em: 12 jan. 2026.